2540 Stock Overview
Yomeishu Seizo Co.,Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Yomeishu Seizo Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,316.00 |
52 Week High | JP¥2,324.00 |
52 Week Low | JP¥1,803.00 |
Beta | 0.080 |
1 Month Change | 21.89% |
3 Month Change | 22.47% |
1 Year Change | 23.13% |
3 Year Change | 25.19% |
5 Year Change | 8.94% |
Change since IPO | 5.27% |
Recent News & Updates
Shareholder Returns
2540 | JP Beverage | JP Market | |
---|---|---|---|
7D | 7.8% | 3.0% | -1.0% |
1Y | 23.1% | 7.9% | 27.9% |
Return vs Industry: 2540 exceeded the JP Beverage industry which returned 7.9% over the past year.
Return vs Market: 2540 underperformed the JP Market which returned 27.9% over the past year.
Price Volatility
2540 volatility | |
---|---|
2540 Average Weekly Movement | 2.5% |
Beverage Industry Average Movement | 3.4% |
Market Average Movement | 4.1% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 2540 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2540's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1923 | 290 | Taro Shiozawa | www.yomeishu.co.jp |
Yomeishu Seizo Co.,Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan. It offers quasi-drugs comprising Yomeishu, a herbal liqueur; gummies and supplements, candies, black vinegar drinks, and home brewed mirins; sake comprising liquor, wine, and cocktails; and ginger black vinegar, black soyabean vinegar, and Amazake.
Yomeishu Seizo Co.,Ltd. Fundamentals Summary
2540 fundamental statistics | |
---|---|
Market cap | JP¥32.01b |
Earnings (TTM) | JP¥557.00m |
Revenue (TTM) | JP¥10.27b |
57.5x
P/E Ratio3.1x
P/S RatioIs 2540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2540 income statement (TTM) | |
---|---|
Revenue | JP¥10.27b |
Cost of Revenue | JP¥4.14b |
Gross Profit | JP¥6.14b |
Other Expenses | JP¥5.58b |
Earnings | JP¥557.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
Earnings per share (EPS) | 40.29 |
Gross Margin | 59.73% |
Net Profit Margin | 5.42% |
Debt/Equity Ratio | 0% |
How did 2540 perform over the long term?
See historical performance and comparison